Table. 1.
Patient characteristics
| Age, median (range) | 60 (17–85) |
| No. of patients, n | 39 |
| Atypical carcinoid of the lung | 5 |
| Gastric neuroendocrine tumor | 1 |
| Pancreatic neuroendocrine tumor | 8 |
| Midgut neuroendocrine tumor | 6 |
| Hindgut neuroendocrine tumor | 2 |
| Neuroendocrine tumor of unknown primary | 4 |
| Neuroendocrine carcinoma | 6 |
| Medullary thyroid carcinoma | 2 |
| Atypical meningioma | 1 |
| Merkel cell carcinoma | 1 |
| Paraganglioma | 1 |
| Neuroendocrine prostate cancer | 1 |
| Renal neuroendocrine tumor | 1 |
| Site of metastasis, n | |
| Liver | 32 |
| Bone | 30 |
| Lymph node | 15 |
| Other | 8 |
| Previous therapies | |
| PRRT | 32 |
| SSA | 21 |
| Chemo | 19 |
| Everolimus | 8 |
| Sunitinib | 6 |
| Radioembolization | 4 |
| Interferon | 2 |
| Prior lines of systemic treatment, n | |
| 0 | 2 |
| 1 | 12 |
| 2 | 8 |
| 3 | 5 |
| 4 | 8 |
| 5 | 3 |
| >5 | 1 |